Listing of Biosergen AB, on Nasdaq First North Growth Market On request of Biosergen AB (publ), company registration number 559304-1295, Nasdaq Stockholm AB has admitted the company's shares and equity rights to trading on Nasdaq First North Growth Market Sweden with effect from June 24, 2021. Shares Short name: BIOSGN ---------------------------------------------------------------- Maximum number of shares to be listed: 28 101 775 ---------------------------------------------------------------- ISIN code: SE0016013460 ---------------------------------------------------------------- Round Lot: 1 ---------------------------------------------------------------- Order book ID: 228458 ---------------------------------------------------------------- Company Registration Number: 559304-1295 ---------------------------------------------------------------- Market segment: First North STO/8 ---------------------------------------------------------------- Tick Size table: MiFID II tick size table ---------------------------------------------------------------- MIC code: SSME ---------------------------------------------------------------- Trading currency: SEK ---------------------------------------------------------------- Equity rights Short name: BIOSGN TO1 ---------------------------------------------------------------------- Maximum number of warrants to be listed: 5 000 000 ---------------------------------------------------------------------- Terms: 1 TO 1 entitles to 1 share ---------------------------------------------------------------------- Subscription period: May 30, 2022 - June 10, 2022 ---------------------------------------------------------------------- Subscription price: SEK 20.00 ---------------------------------------------------------------------- Last trading day: June 8, 2022 ---------------------------------------------------------------------- ISIN code: SE0016013478 ---------------------------------------------------------------------- Round Lot: 1 ---------------------------------------------------------------------- Order book ID: 228459 ---------------------------------------------------------------------- Market segment: First North STO/8 ---------------------------------------------------------------------- Tick Size table: MiFID II tick size table ---------------------------------------------------------------------- MIC code: SSME ---------------------------------------------------------------------- Trading currency: SEK ---------------------------------------------------------------------- Classification Code Name ----------------- 20 Health Care ----------------- 2010 Health Care ----------------- This information is distributed at the request of the Certified Adviser, Erik Penser Bank AB. For further information, please call Erik Penser Bank AB on +46846380000.
Nasdaq Stockholm AB: Listing of Biosergen AB, on Nasdaq First North Growth Market (340/21)
© 2021 GlobeNewswire
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen.
Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen,
bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen
Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu
verstehen sein kann.
